Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer

Annals of Surgery

Volumn 232, Issue 1, 2000, Pages 66-72

  Weitz, Jürgen ^a   Koch, Moritz ^a   Kienle, Peter ^a   Schrödel, Andrea ^a   Willeke, Frank ^a   Benner, Axel ^b   Lehnert, Thomas ^a   Herfarth, Christian ^a   Von Knebel Doeberitz, Magnus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 20;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; LIVER RESECTION; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ADULT; AGED; BONE MARROW; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; INTERMEDIATE FILAMENT PROTEINS; INTRAOPERATIVE PERIOD; KERATIN-20; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0033948945     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200007000-00010     Document Type: Article

References (58)

1. Bengmark S, Hafström L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 1969; 23:198-202.
2. Bengtsson G, Carlsson G, Hafström L, Jönsson PE. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 1981; 141:586-589.
3. Tong D, Russel AH, Dawson LE, Wisbeck W. Second laparotomy for proximal colon cancer: sites of recurrence and implications for adjuvant therapy. Am J Surg 1983; 145:382-385.
4. Finlay IG, McArdle CS. Occult hepatic metastases in colorectal carcinoma. Br J Surg 1986; 73:732-735.
5. Lehnen T, Otto G, Herfarth C. Therapeutic modalities and prognostic factors for primary and secondary liver tumors. World J Surg 1995; 19:252-263.
6. Geoghegan JG, Scheele J. Treatment of colorectal liver metastases. Br J Surg 1999; 86:158-169.
7. Wagner JS, Adson MA, van Heerden JA, et al. The natural history of hepatic metastases from colorectal cancer. Ann Surg 1984; 199:502-508.
8. Ekberg H, Tranberg K-G, Andersson R, et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 1986; 73:727-231.
9. Iwatsuki S, Esquivel CO, Gordon RD, Starzl T. Liver resection for metastatic colorectal cancer. Surgery 1986; 100:804-810.
10. Little JM, Hollands M. Hepatic resection for colorectal metastases-Selection of cases and determinants of success. Austral NZ J Surg 1987; 57:355-359.
11. Schlag P, Hohenberger P, Herfarth C. Resection of liver metastases in colorectal cancer: competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol 1990; 16: 360-365.
12. Yamamoto J, Shimada K, Kosuge T, et al. Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg 1999; 86:332-337.
13. Hughes KS, for the Registry of Hepatic Metastases. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986; 100:278-284.
14. Butler J, Attiyeh FF, Daly JM. Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet 1986; 162:109-113.
15. Nordlinger B, Parc R, Delva E, et al. Hepatic resection for colorectal liver metastases: influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg 1987; 205:256-263.
16. Johnson PWM, Burchill SA, Selby PJ. The molecular detection of circulating tumor cells. Br J Cancer 1995: 72:268-276.
17. Moll R, Löwe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Path 1992; 140:427-447.
18. Moll R, Zimbelmann R, Goldschmidt MD, et al. The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation 1993; 53:75-93.
19. Burchill SA, Bradbury MF, Pittman K, et al. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995; 71:278-281.
20. Soeth E, Rôder C, Juhl H, et al. The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin 20-specific nested reverse transcriptase-polymerase chain reaction is related to the stage of disease. Int J Cancer 1996; 69:278-282.
21. Soeth E, Vogel I, Röder C, et al. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 1997; 57:3106-3110.
22. Weitz J, Kienle P, Lacroix J, et al. Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res 1998; 4:343-348.
23. Weitz J, Kienle P, Magener A, et al. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin Cancer Res 1999; 5:1830-1836.
24. Hsu EM, Mc Nicol PJ, Guijon FB, Paraskevas M. Quantification of HPV-16 E6-E7 transcription in cervical intraepithelial neoplasia by reverse transcriptase polymerase chain reaction. Int J Cancer 1993; 55:397-401.
25. Bismuth H, Houssin DH, Castaing D. Major and minor segmentectomies in liver surgery. World J Surg 1982; 6:10-24.
26. Fleiss JL. Statistical Methods for Rates and Proportions, 2d ed. New York: John Wiley & Sons; 1973.
27. Breslow NE, Day NE. Statistical methods in cancer research, Vol. 1. The analysis of case-control studies. IARC Scientific Publication No. 32. Lyon: IARC; 1980.
28. Agresti A. Categorical Data Analysis. New York: John Wiley & Sons; 1990.
29. O'Connell JM, Adson MA, Schutt AJ, et al. Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Mayo Clin Proc 1985; 60:517-520.
30. Elias D, Lasser P, Rougier P, et al. Early adjuvant intraportal chemotherapy after curative hepatectomy for colorectal liver metastases: a pilot study. Eur J Surg Oncol 1987; 13:247-250.
31. Lorenz M, Muller H-H, Schramm H, et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. Ann Surg 1998; 228:756-762.
32. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991; 110:13-29.
33. Pedersen IK, Burcharth F, Roikjaer O, Baden H. Resection of liver metastases from colorectal cancer. Dis Colon Rectum 1994; 37:1078-1082.
34. Busch E, Kenieny MM. Colorectal cancer: hepatic-directed therapy -the role of surgery, regional chemotherapy and novel modalities. Semin Oncol 1995; 22:494-508.
35. Jaeck D, Bachellier P, Guiguet M, et al. Long-term survival following resection of colorectal hepatic metastases. Br J Surg 1997; 84,977-980.
36. Elias D, Cavalcanti A, Sabourin JC, et al. Resection of liver metastases from colorectal cancer: the real impact of the surgical margin. Eur J Surg Oncol 1998; 24:174-179.
37. Ekberg H, Tranberg KG, Andersson R, et al. Pattern of recurrence in liver resection for colorectal secondaries. World J Surg 1987; 11:541-547.
38. 125I-iodo-2′-deoxyuridine. J Natl Cancer Inst 1970; 45:773-782.
39. Weiss L. Metastatic inefficiency. Adv Cancer Res 1990; 54:159-211.
40. Fidler IJ. The biology of human cancer metastasis. Acta Oncol 1991; 30:669-675.
41. Fidler IJ. Macrophages and metastasis: a biological approach to cancer therapy. Cancer Res 1985; 45:4714-4726.
42. Romsdahl MM, McGrath RG, Hoppe E, McGrew EA. Experimental model for the study of tumor cells in the blood. Acta Cytol 1965; 9:141-145.
43. Liotta LA, Kleinerman J, Saidel GM. Quantitative relationships of intravascular tumor cells, tumor vessel and pulmonary metastasis following tumor implantation. Cancer Res 1974; 34:997-1004.
44. Tyzzer EE. Factors in the production and growth of tumor metastasis. J Med Res 1913; 28:309-331.
45. Nishizaki T, Matsumata T, Kanematsu T. Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastasis. J Surg Res 1990; 49:92-97.
46. Brown DC, Purushotham AD, Birnie GD, George WD. Detection of intraoperative tumor cell dissemination in patients with breast cancer by use of reverse transcription-polymerase chain reaction. Surgery 1995; 117:96-101.
47. Glaves D, Huben RP, Weis L. Haematogenous dissemination of cells from human renal adenocarcinomas. Br J Cancer 1988; 57:32-35.
48. Willeke F, Ridder R, Mechtersheimer G, et al. Analysis of FUS-CHOP fusion transcripts in different types of soft tissue liposarcoma and their diagnostic implications. Clin Cancer Res 1998; 4:1779-1884.
49. Eschwege P, Dumas F, Blanchet P, et al. Hematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet 1995; 346:1528-1530.
50. Barnes JP. Physiologic resection of the right colon. Surg Gynecol Obstet 1952; 94:722-726.
51. Turnbull RB, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg 1967; 166:420-425.
52. Bismuth H. Surgical anatomy and anatomical surgery of the liver. World J Surg 1982; 6:3-9.
53. Koo J, Fung K, Siu KF, et al. Recovery of malignant tumor cells from the right atrium during hepatic resection for hepatocellular carcinoma. Cancer 1983; 52:1952-1956.
54. Lemoine A, Le Bricon T, Salvussi M, et al. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery. Ann Surg 1997; 226:43-50.
55. Glaves D. Correlation between circulating cancer cells and incidence of metastases. Br J Cancer 1983; 48:665-673.
56. Mayhew E, Glaves D. Quantitation of the tumorigenic disseminating and arrested cancer cells. Br J Cancer 1984; 50:159-166.
57. Lai ECS, Fan ST, Lo CM, et al. Anterior approach for difficult major right hemihepatectomy. World J Surg 1996; 20:314-318.
58. Hohenberger P. Right hemihepatectomy: frontal approach. Alternative to conventional procedures. Chirurgie 1996; 67:944-948.